These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 14621044)

  • 41. Reduced-intensity conditioning followed by allografting of CD34-selected stem cells and < or =10(6)/kg T cells may have an adverse effect on transplant-related mortality.
    Hartwig UF; Winkelmann N; Wehler T; Kreiter S; Schneider PM; Meyer RG; Ullmann AJ; Huber C; Kolbe K; Herr W
    Ann Hematol; 2005 May; 84(5):331-8. PubMed ID: 15726363
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Allogeneic blood stem cell transplantation in chronic myeloid leukaemia-chronic phase following conditioning with busulphan and cyclophosphamide: a follow up report.
    Saikia TK; Parikh PM; Tawde S; Amare-Kadam PS; Rajadhyaksha S; Chhaya S
    Natl Med J India; 2004; 17(2):71-3. PubMed ID: 15141598
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body irradiation, for alternative donor transplants, in acquired severe aplastic anemia: a retrospective study from the EBMT-SAA Working Party.
    Bacigalupo A; Socie' G; Lanino E; Prete A; Locatelli F; Locasciulli A; Cesaro S; Shimoni A; Marsh J; Brune M; Van Lint MT; Oneto R; Passweg J;
    Haematologica; 2010 Jun; 95(6):976-82. PubMed ID: 20494932
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pilot trial of risk-adapted cyclophosphamide intensity based conditioning and HLA matched sibling and unrelated cord blood stem cell transplantation in newly diagnosed pediatric and adolescent recipients with acquired severe aplastic anemia.
    McGuinn C; Geyer MB; Jin Z; Garvin JH; Satwani P; Bradley MB; Bhatia M; George D; Duffy D; Morris E; van de Ven C; Schwartz J; Baxter-Lowe LA; Cairo MS
    Pediatr Blood Cancer; 2014 Jul; 61(7):1289-94. PubMed ID: 24623601
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Seventeen cases of nonmyeloablative stem cell transplantation using a conditioning regimen containing fludarabine].
    Wu DP; Ma X; Sun AN; Fu ZZ; Tang XW; Qiu HY; Miao M; Liu YJ; Li CX; Xia XM; Lin BJ
    Zhonghua Xue Ye Xue Za Zhi; 2003 Aug; 24(8):410-2. PubMed ID: 14642177
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Successful T-cell-depleted, related haploidentical peripheral blood stem cell transplantation in a patient with Fanconi anaemia using a fludarabine-based preparative regimen without radiation.
    Rossi G; Giorgiani G; Comoli P; Nobili B; Salvaneschi L; De Stefano P; Maccario R; Locatelli F
    Bone Marrow Transplant; 2003 Mar; 31(6):437-40. PubMed ID: 12665837
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Modified conditioning regimen busulfan-cyclophosphamide followed by allogeneic stem cell transplantation in patients with multiple myeloma.
    Zhang XH; Huang XJ; Liu KY; Xu LP; Liu DH; Chen H; Chen YH; Wang JZ; Han W; Lu DP
    Chin Med J (Engl); 2007 Mar; 120(6):463-8. PubMed ID: 17439737
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reduced intensity conditioning using intravenous busulfan, fludarabine and rabbit ATG for children with nonmalignant disorders and CML.
    Horn B; Baxter-Lowe LA; Englert L; McMillan A; Quinn M; Desantes K; Cowan M
    Bone Marrow Transplant; 2006 Feb; 37(3):263-9. PubMed ID: 16327813
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reduced-intensity conditioning for severe aplasia using fludarabine and CY followed by infusion of ex vivo T-cell-depleted grafts leads to excellent engraftment and absence of GVHD.
    Novitzky N; Thomas V; du Toit C; McDonald A
    Bone Marrow Transplant; 2009 May; 43(10):779-85. PubMed ID: 19079315
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High-dose peripheral blood stem cell transplant for multitransfused severe aplastic anaemia patients without antithymocyte globulin in the conditioning regimen.
    Herrera-Garza J; Jaime-Pérez J; Montemayor J; Ibarra-Peart R; Gómez-Almaguer D
    Bone Marrow Transplant; 1999 Oct; 24(8):845-8. PubMed ID: 10516694
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Donor stem cell infusion after non-myeloablative conditioning for tolerance induction to HLA mismatched adult living-donor liver graft.
    Donckier V; Troisi R; Toungouz M; Colle I; Van Vlierberghe H; Jacquy C; Martiat P; Stordeur P; Zhou L; Boon N; Lambermont M; Schandené L; Van Laethem JL; Noens L; Gelin M; de Hemptinne B; Goldman M
    Transpl Immunol; 2004; 13(2):139-46. PubMed ID: 15380544
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reduced dose cyclophosphamide, fludarabine and antithymocyte globulin for sibling and unrelated transplant of children with severe and very severe aplastic anemia.
    Chung NG; Lee JW; Jang PS; Jeong DC; Cho B; Kim HK
    Pediatr Transplant; 2013 Jun; 17(4):387-93. PubMed ID: 23551397
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Allogenic hematopoietic stem cell transplantation in acquired aplastic anemia: first experience of the National Center for Bone Marrow Grafting].
    Abdelkefi A; Ladeb S; Ben Othman T; Torjman L; Jeddi R; Ben Abdeladhim A
    Tunis Med; 2001 Oct; 79(10):498-502. PubMed ID: 11910688
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Control of advanced and refractory acute myelogenous leukaemia with sirolimus-based non-myeloablative allogeneic stem cell transplantation.
    Claxton DF; Ehmann C; Rybka W
    Br J Haematol; 2005 Jul; 130(2):256-64. PubMed ID: 16029454
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Second nonmyeloablative allogeneic peripheral blood stem cell transplantation with more immunosuppressive conditioning regimen for the late graft failure of the patient with acute myeloid leukemia].
    Tachikawa Y; Abe Y; Choi I; Ohtsuka R; Nagasawa E; Shibata K; Nishimura J; Nawata H; Muta K
    Fukuoka Igaku Zasshi; 2005 Nov; 96(11):378-82. PubMed ID: 16502857
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The outcome of children with Fanconi anemia given hematopoietic stem cell transplantation and the influence of fludarabine in the conditioning regimen: a report from the Italian pediatric group.
    Locatelli F; Zecca M; Pession A; Morreale G; Longoni D; Di Bartolomeo P; Porta F; Fagioli F; Nobili B; Bernardo ME; Messina C;
    Haematologica; 2007 Oct; 92(10):1381-8. PubMed ID: 18024375
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Risk-adapted procedures for HSCT from alternative donor in children with severe aplastic anaemia.
    Führer M
    Bone Marrow Transplant; 2008 Oct; 42 Suppl 2():S97-100. PubMed ID: 18978755
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Low toxicity of a conditioning with 8-Gy total body irradiation, fludarabine and cyclophosphamide as preparative regimen for allogeneic hematopoietic stem cell transplantation in pediatric hematological malignancies.
    Yanagisawa R; Nakazawa Y; Sakashita K; Tanaka M; Shikama N; Kamijo T; Shiohara M; Koike K
    Pediatr Transplant; 2009 Sep; 13(6):737-45. PubMed ID: 19207225
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Allogeneic hematopoietic stem cell transplantation for childhood aplastic anemia: prospective trial in China.
    Chun C; Fang JP; Xue HM; Zhou DH; Huang K; Xu HG; Huang SL
    Transfus Apher Sci; 2011 Feb; 44(1):41-7. PubMed ID: 21256085
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cyclophosphamide and antithymocyte globulin as a conditioning regimen for allogeneic marrow transplantation in patients with aplastic anaemia: a long-term follow-up.
    Kahl C; Leisenring W; Deeg HJ; Chauncey TR; Flowers ME; Martin PJ; Sanders JE; Storb R
    Br J Haematol; 2005 Sep; 130(5):747-51. PubMed ID: 16115132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.